Crestwood Advisors Group LLC Merck & Co., Inc. Transaction History

Crestwood Advisors Group LLC

  • $5.07 Billion
  • Q1 2025

A detailed history of Crestwood Advisors Group LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Crestwood Advisors Group LLC holds 109,751 shares of MRK stock, worth $8.21 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
109,751
Previous 116,871 6.09%
Holding current value
$8.21 Million
Previous $11.6 Million 15.27%
% of portfolio
0.19%
Previous 0.23%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 05, 2025
SELL
$83.01 - $101.02 $591,031 - $719,262
-7,120 Reduced 6.09%
109,751 $9.85 Million
Q4 2024

Feb 04, 2025
SELL
$96.31 - $114.76 $567,843 - $676,624
-5,896 Reduced 4.8%
116,871 $11.6 Million
Q3 2024

Oct 30, 2024
BUY
$111.15 - $128.97 $43,570 - $50,556
392 Added 0.32%
122,767 $13.9 Million
Q2 2024

Aug 01, 2024
BUY
$123.8 - $132.96 $191,394 - $205,556
1,546 Added 1.28%
122,375 $15.2 Million
Q1 2024

May 08, 2024
BUY
$113.24 - $131.95 $318,657 - $371,307
2,814 Added 2.38%
120,829 $15.9 Million
Q4 2023

Jan 29, 2024
SELL
$100.18 - $109.02 $290,822 - $316,485
-2,903 Reduced 2.4%
118,015 $12.9 Million
Q3 2023

Nov 15, 2023
BUY
$102.95 - $114.33 $1.26 Million - $1.4 Million
12,281 Added 11.3%
120,918 $12.4 Million
Q2 2023

Aug 15, 2023
SELL
$108.61 - $118.38 $6.17 Million - $6.73 Million
-56,809 Reduced 34.34%
108,637 $12.5 Million
Q1 2023

May 12, 2023
SELL
$102.94 - $114.86 $514,082 - $573,610
-4,994 Reduced 2.93%
165,446 $17.6 Million
Q4 2022

Feb 14, 2023
SELL
$87.44 - $112.11 $3.19 Million - $4.09 Million
-36,452 Reduced 17.62%
170,440 $18.9 Million
Q3 2022

Oct 26, 2022
BUY
$84.53 - $94.96 $83,515 - $93,820
988 Added 0.48%
206,892 $17.8 Million
Q2 2022

Jul 07, 2022
BUY
$83.49 - $94.64 $97,349 - $110,350
1,166 Added 0.57%
205,904 $18.8 Million
Q1 2022

Apr 12, 2022
SELL
$73.51 - $82.4 $305,360 - $342,289
-4,154 Reduced 1.99%
204,738 $16.8 Million
Q4 2021

Feb 15, 2022
SELL
$72.28 - $90.54 $432,234 - $541,429
-5,980 Reduced 2.78%
208,892 $16 Million
Q3 2021

Nov 03, 2021
SELL
$71.68 - $78.83 $647,485 - $712,071
-9,033 Reduced 4.03%
214,872 $16.1 Million
Q2 2021

Aug 13, 2021
BUY
$70.31 - $77.77 $746,903 - $826,150
10,623 Added 4.98%
223,905 $17.4 Million
Q1 2021

Apr 21, 2021
SELL
$68.86 - $81.11 $153,213 - $180,469
-2,225 Reduced 1.03%
213,282 $15.7 Million
Q4 2020

Feb 09, 2021
BUY
$71.77 - $79.65 $3.24 Million - $3.6 Million
45,160 Added 26.51%
215,507 $17.6 Million
Q3 2020

Oct 06, 2020
SELL
$73.18 - $82.95 $97,402 - $110,406
-1,331 Reduced 0.78%
170,347 $14.1 Million
Q2 2020

Aug 14, 2020
BUY
$70.42 - $80.13 $1.99 Million - $2.27 Million
28,270 Added 19.71%
171,678 $12.7 Million
Q1 2020

May 15, 2020
BUY
$63.36 - $87.82 $85,599 - $118,644
1,351 Added 0.95%
143,408 $11 Million
Q4 2019

Feb 12, 2020
BUY
$77.58 - $87.54 $180,994 - $204,230
2,333 Added 1.67%
142,057 $12.9 Million
Q3 2019

Nov 13, 2019
BUY
$76.08 - $82.93 $748,551 - $815,948
9,839 Added 7.58%
139,724 $11.8 Million
Q2 2019

Aug 14, 2019
BUY
$69.84 - $81.59 $8.33 Million - $9.73 Million
119,295 Added 1126.49%
129,885 $10.9 Million
Q1 2019

May 09, 2019
BUY
$69.58 - $79.36 $89,340 - $101,898
1,284 Added 13.8%
10,590 $881,000
Q4 2018

Feb 14, 2019
SELL
$65.24 - $75.71 $42,862 - $49,741
-657 Reduced 6.59%
9,306 $711,000
Q2 2018

Aug 14, 2018
SELL
$50.83 - $59.72 $26,889 - $31,591
-529 Reduced 5.04%
9,963 $0
Q1 2018

May 14, 2018
SELL
$50.96 - $59.23 $71,344 - $82,922
-1,400 Reduced 11.77%
10,492 $571,000
Q4 2017

Jan 11, 2018
SELL
$51.62 - $61.64 $44,238 - $52,825
-857 Reduced 6.72%
11,892 $669,000
Q3 2017

Nov 20, 2017
BUY
$58.67 - $63.13 $747,983 - $804,844
12,749
12,749 $816,000

Others Institutions Holding MRK

# of Institutions
3,889
Shares Held
1.93B
Call Options Held
24.5M
Put Options Held
21.4M
View Full List

About Merck & Co., Inc.

MRK Quotes by TradingView
  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $189B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Crestwood Advisors Group LLC Portfolio

Follow Crestwood Advisors Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crestwood Advisors Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Crestwood Advisors Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email